Insider buying last 90 days
$986Kin 1 open-market purchase
| Filed | Insider | Type | Value |
|---|---|---|---|
| Oct 29 | KOCH D CHRISTIAN director | Purchase | $986K |
From Form 4 filings, dated to when each was filed.
Xylem completed its acquisition of Cornell Pump and Roper Pump, expanding its capabilities in industrial markets such as mining, power, semiconductors, and food and beverage. The move follows the company's Q3 2026 results, which were mixed, with revenue missing expectations due to slower project execution and cautious utility spending, though orders remained healthy; Xylem also announced plans to divest Applied Water International and Specialty Flow Control and to restructure from four to three segments in 2027. Separately, Xylem reported Q3 EPS of US$1.25, up from US$0.93 a year earlier, while trimming its full-year 2026 revenue outlook.
Shares closed at $99.26, up 1.5%, but remain below both the 50-day average of $103.31 and the 200-day average of $115.98, with the 50-day below the 200-day. The GekkoIndex reading sits at 58, placing the stock in the Neutral zone. Price stands 23.3% below Gekko Fair Value of $129.37.
The next earnings date falls on 9 February 2027, 86 days away, outside a typical 20-trading-day holding window. Over the last 90 days, smart money activity includes one open-market insider purchase and one Congress buy with no sales. Seasonality over the next 20 trading days has averaged -0.3% across 5 years, rising in 3 of them. Analyst consensus among 15 firms includes 8 buy, 6 hold, and 1 sell ratings, with a consensus target of $125.44.
Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.
Xylem scores 4 supportive, 1 mixed and 1 headwind across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
4 supportive1 mixed1 headwind
Below 50 and 200-day
Close $94.18 is below the 50-day ($102.28) and 200-day ($115.10) averages, and the 50-day is below the 200-day.
See the chart61, Accumulation
Reading 61 is in the Accumulation zone.
See the GekkoIndex24.7% below
Price is 24.7% below Gekko Fair Value (more than 5% below).
See fair valueLeans bullish
Last 90 days: 1 open-market insider purchase; Congress 1 buy / 0 sales. Last 30 days: 1 unusual options signal.
See smart moneyReports in 86 days
Next report Feb 9, 2027, 86 days away — outside a typical 20-trading-day hold.
See earnings0.0% on average
From this point in the calendar, the next 20 trading days averaged 0% over 5 years, rising in 2 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Xylem closed at $94.18 on Nov 13, 2026, −37.2% over the past year, inside a 52-week range of $87.40 to $150.51.
Use the left and right arrow keys to read daily values.
Put XYL on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Xylem designs, manufactures, and services engineered equipment and systems that move, treat, and monitor water for utilities, industrial operators, and residential and commercial building customers around the world. It is widely recognized for its pumps, controls, and treatment equipment sold under brand names such as Flygt, Goulds Water Technology, Sensus, and Wedeco, which serve tasks ranging from moving wastewater to filtering and disinfecting water supplies.
The company is structured into segments covering water infrastructure, applied water systems, measurement and control solutions, and broader water services. Its offerings span physical hardware like pumps, valves, and heat exchangers to smart meters, sensors, software, and cloud-based data analytics, along with maintenance, emergency response, dewatering, and municipal services such as odor control and asset condition monitoring. Customers include utilities, industrial facilities, and residential and commercial building operators that rely on these tools for water-related infrastructure needs.
Xylem is headquartered in Washington, District of Columbia. It traces back to an entity formerly called ITT WCO, Inc., which was renamed Xylem in July 2011 and incorporated that same year. Its shares are listed on the NYSE under the ticker XYL.
Xylem’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 61, in the Accumulation zone, up 2.5 points over five sessions.
Up 2.5 points over five sessions, from the Neutral zone.
Reading for Nov 13, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 36 | +2.2% | +3.0% | ||
| Accumulation (current zone) | 245 | −0.3% | −0.3% | ||
| Neutral | 371 | −0.1% | −0.5% | ||
| Distribution | 48 | +0.6% | +0.3% | ||
| Selling | 2 | Too few readings yet | |||
Average XYL share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.0% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
Xylem trades 24.7% below Gekko Fair Value of $125.10, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Xylem shares are worth, recalculated every trading day.
$125.10
Gekko Fair Value, Nov 14, 2026
24.7% Undervalued
At the end of Aug 2026 the price was 23.3% below the estimate.
Insiders filed 1 open-market purchase in Xylem worth $986K, and members of Congress disclosed 1 purchase and 0 sales, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
$986Kin 1 open-market purchase
| Filed | Insider | Type | Value |
|---|---|---|---|
| Oct 29 | KOCH D CHRISTIAN director | Purchase | $986K |
From Form 4 filings, dated to when each was filed.
1trade disclosed: 1 purchase and 0 sales.
| Member | Amount | Disclosed |
|---|---|---|
| Ro Khanna House, CA, purchase | $1,001 - $15,000 | Oct 9 traded Sep 25 |
From congressional disclosures, which report amounts as ranges.
Xylem has been buying back its own shares.
From company filings.
1signal, 11% of the flagged premium in calls.
Latest: Bearish flow on Nov 11, $501K in unusual premium.
1of the funds Gekko tracks holds XYL.
Xylem reports on Feb 9, 2027, before the open (86 days away), and beat the EPS estimate in 7 of its last 8 reports.
Feb 9, 2027
Expected before the open, 86 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Oct 27, 2026 | $1.44 est $1.45 | $2.20B est $2.28B | −18.5% |
| Jul 28, 2026 | $1.46 est $1.34 | $2.34B est $2.34B | +1.6% |
| Apr 28, 2026 | $1.12 est $1.09 | $2.13B est $2.11B | −6.6% |
| Feb 10, 2026 | $1.42 est $1.41 | $2.40B est $2.37B | −9.6% |
| Oct 28, 2025 | $1.37 est $1.23 | $2.27B est $2.22B | +2.4% |
| Jul 31, 2025 | $1.26 est $1.15 | $2.30B est $2.21B | +8.9% |
| Apr 29, 2025 | $1.03 est $0.96 | $2.07B est $2.04B | +4.0% |
| Feb 4, 2025 | $1.18 est $1.13 | $2.26B est $2.18B | +5.7% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Xylem is $125.44, +33.2% from the last close, from 15 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 15 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 4 | Argus Research | — | — |
| Oct 29 | UBS | $99 | +5.1% |
| Oct 28 | J.P. Morgan | $90 | −4.4% |
| Oct 28 | Citi | $130 | +38.0% |
| Oct 28 | Stifel Nicolaus | $114 | +21.0% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 14, Xylem averaged 0.0% across the last 5 years, rising in 2 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −0.2% | 1 of 5 |
| Next 10 trading days | −0.8% | 3 of 5 |
| Next 15 trading days | +0.3% | 3 of 5 |
| Next 20 trading days | 0.0% | 2 of 5 |
| Next 30 trading days | −0.7% | 1 of 5 |
For scale, XYL’s typical 20-trading-day move in either direction is about 5%.
Xylem’s market cap is $21.60B, with a P/E ratio of 20.9 and revenue of $9.06B over the last twelve months.
Coverage of Xylem this week reads positive: 13 positive, 5 neutral and 4 negative headlines.
Xylem’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| AMATApplied Materials | Accumulation | 27.3% below |
| LRCXLam Research | Accumulation | 14.7% below |
| PHParker-Hannifin | Neutral | 4.5% above |
| TTTrane Technologies | Accumulation | 6.8% above |
| JCIJohnson Controls International | Accumulation | 6.6% above |
| CARRCarrier Global | Neutral | 0.0% above |
A peer links to its own page where one exists.
Xylem’s market cap is $21.60B at the Nov 13, 2026 close of $94.18, with 229.3M shares outstanding. The shares trade on a P/E ratio of 20.9.
The consensus analyst 12-month price target for Xylem is $125.44, +33.2% from the last close. Of the 15 firms that rated the stock in the last 90 days, 8 rate it a buy, 6 a hold and 1 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Xylem is undervalued: the Nov 13, 2026 close of $94.18 is 24.7% below Gekko Fair Value of $125.10. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Xylem is expected to report on Feb 9, 2027, before the market opens (86 days away). Analysts expect earnings of $1.45 per share on revenue of $2.30B. Xylem beat the earnings estimate in 7 of its last 8 reports, moving 7.2% on average across the report.
Xylem’s 52-week high is $150.51 and its 52-week low is $87.40; it closed at $94.18 on Nov 13, 2026, −37.2% over the past year. Over the last five years the shares peaked at $154.27 on Oct 30, 2025.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 4 of the 6 items with data read as supportive (gekkoindex, fair value, smart money and earnings risk), 1 as mixed (seasonality) and 1 as a headwind (trend). The checklist is a description of current data, not a recommendation.
Gekko flagged 1 unusual options signal in Xylem over the last 30 days, with $53K of flagged premium in calls and $447K in puts. The latest, bearish flow, was on Nov 11, 2026 with $501K in unusual premium. The signal-by-signal table is in Gekko.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,475 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.